STOCK TITAN

Assertio (ASRT) insider 10b5‑1 sale: 8,959 shares at $0.7597

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Assertio Holdings (ASRT): A company director reported an open‑market sale of 8,959 shares of common stock on 11/10/2025 at a $0.7597 weighted average price. The sale was made under a Rule 10b5‑1 trading plan adopted on November 22, 2024. Following the transaction, the director reported 98,541 shares beneficially owned, held directly. The trade included multiple executions between $0.7544 and $0.7668 per share.

Positive

  • None.

Negative

  • None.

Insights

Routine 10b5‑1 insider sale with modest size; neutral signal.

An ASRT director sold 8,959 shares on 11/10/2025 at a weighted average of $0.7597, executed via a pre‑arranged Rule 10b5‑1 plan adopted on November 22, 2024. Such plans automate trades and can reduce concerns about trade timing.

The filing lists a post‑trade direct stake of 98,541 shares. The sales occurred in multiple prints between $0.7544 and $0.7668. The filing does not indicate changes to strategy or operations; actual market impact typically depends on overall liquidity and float.

Because the transaction is scheduled under a 10b5‑1 plan and small in scale, it is generally viewed as administrative rather than thesis‑altering.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stark David Matthew

(Last) (First) (Middle)
ASSERTIO HOLDINGS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300

(Street)
LAKE FOREST IL 60045

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Assertio Holdings, Inc. [ ASRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/10/2025 S(1) 8,959 D $0.7597(2) 98,541 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024.
2. The price reported is a weighted average sale price. The shares were sold in multiple same-way transactions on November 10, 2025, at prices ranging from $0.7544 to $0.7668 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock sold at each separate price.
/s/ Sam Schlessinger, Attorney-in-fact for David M. Stark 11/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ASRT report?

A director sold 8,959 shares of common stock on 11/10/2025 at a weighted average price of $0.7597.

Was the ASRT insider sale under a Rule 10b5-1 plan?

Yes. The sale was made pursuant to a Rule 10b5‑1 trading plan adopted on November 22, 2024.

What is the insider’s ASRT share ownership after the sale?

Following the transaction, the director reported 98,541 shares beneficially owned, held directly.

What price range were ASRT shares sold at in this transaction?

Trades were executed between $0.7544 and $0.7668 per share, resulting in a $0.7597 weighted average.

What role does the reporting person hold at ASRT?

The reporting person is a Director of Assertio Holdings, Inc.

How was the Form 4 filed for ASRT?

It was signed by /s/ Sam Schlessinger as attorney‑in‑fact for David M. Stark on 11/12/2025.
Assertio Holdings Inc

NASDAQ:ASRT

View ASRT Stock Overview

ASRT Rankings

ASRT Latest News

ASRT Latest SEC Filings

ASRT Stock Data

88.43M
6.27M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
LAKE FOREST